Senter syndrome

From WikiMD's Food, Medicine & Wellness Encyclopedia

Senter syndrome is a rare genetic disorder characterized by pigmentation abnormalities, sensorineural hearing loss, and peripheral neuropathy. The syndrome is named after the researcher who first described it, Dr. Senter.

Symptoms and Signs[edit | edit source]

The primary symptoms of Senter syndrome include:

  • Pigmentation abnormalities: These can range from hypopigmentation (reduced pigmentation) to hyperpigmentation (increased pigmentation), and can affect any part of the body.
  • Sensorineural hearing loss: This is a type of hearing loss in which the root cause lies in the inner ear or sensory organ (cochlea and associated structures) or the vestibulocochlear nerve (cranial nerve VIII).
  • Peripheral neuropathy: This is a result of damage to the peripheral nerves, often causing weakness, numbness and pain, usually in the hands and feet.

Causes[edit | edit source]

Senter syndrome is caused by mutations in the MITF gene. This gene provides instructions for making a protein that plays a role in the development of several types of cells, including melanocytes (cells that produce the pigment melanin), osteoclasts (cells that break down bone), and mast cells (cells that play a role in the immune system).

Diagnosis[edit | edit source]

Diagnosis of Senter syndrome is based on the presence of the characteristic symptoms and confirmed by genetic testing showing a mutation in the MITF gene.

Treatment[edit | edit source]

There is currently no cure for Senter syndrome. Treatment is symptomatic and supportive, and may include hearing aids for sensorineural hearing loss and physical therapy for peripheral neuropathy.

See also[edit | edit source]

References[edit | edit source]

Senter syndrome Resources
Doctor showing form.jpg
Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Admin, Prab R. Tumpati, MD